The Sybil Implementation Consortium Mission
The current state of lung cancer screening in the U.S. has failed patients in both reach and grasp: we are not screening all high-risk patients nor are we providing appropriate screening and follow-up to those who qualify.
The consortium was inspired by three principles that guide our work:
- No one deserves lung cancer
- Anyone with lungs can get lung cancer
- Screening high risk people for lung cancer improves outcomes.
However, the current state of lung cancer screening in the U.S. has failed patients in both reach and grasp: we are not enabling screening for all high-risk patients (half of those diagnosed with lung cancer would not have qualified for screening), nor are we ensuring appropriate screening and follow-up to those who qualify.
The Consortium is using implementation science methods and a wide range of medical and technical expertise to study how best to deploy Sybil in the real world, in a way that can be replicated in diverse health care settings and employed to help guide a variety of clinical care needs.
We believe the foundational work we are conducting as a consortium will transform and elevate Sybil from its current state as a validated risk classifier to a useable, practical, clinical tool that can dramatically improve early lung cancer detection. The work of the consortium will lead to a future with simplified and equitable access to lung screening.
